全文获取类型
收费全文 | 27321篇 |
免费 | 1573篇 |
国内免费 | 241篇 |
专业分类
耳鼻咽喉 | 232篇 |
儿科学 | 536篇 |
妇产科学 | 578篇 |
基础医学 | 2762篇 |
口腔科学 | 695篇 |
临床医学 | 1897篇 |
内科学 | 7862篇 |
皮肤病学 | 349篇 |
神经病学 | 2393篇 |
特种医学 | 1037篇 |
外科学 | 5151篇 |
综合类 | 55篇 |
一般理论 | 5篇 |
预防医学 | 978篇 |
眼科学 | 515篇 |
药学 | 1658篇 |
中国医学 | 55篇 |
肿瘤学 | 2377篇 |
出版年
2023年 | 271篇 |
2022年 | 233篇 |
2021年 | 780篇 |
2020年 | 579篇 |
2019年 | 825篇 |
2018年 | 992篇 |
2017年 | 732篇 |
2016年 | 860篇 |
2015年 | 894篇 |
2014年 | 1215篇 |
2013年 | 1501篇 |
2012年 | 2284篇 |
2011年 | 2173篇 |
2010年 | 1246篇 |
2009年 | 1207篇 |
2008年 | 1883篇 |
2007年 | 1841篇 |
2006年 | 1715篇 |
2005年 | 1695篇 |
2004年 | 1595篇 |
2003年 | 1369篇 |
2002年 | 1230篇 |
2001年 | 127篇 |
2000年 | 125篇 |
1999年 | 157篇 |
1998年 | 166篇 |
1997年 | 140篇 |
1996年 | 131篇 |
1995年 | 147篇 |
1994年 | 123篇 |
1993年 | 115篇 |
1992年 | 90篇 |
1991年 | 68篇 |
1990年 | 71篇 |
1989年 | 52篇 |
1988年 | 42篇 |
1987年 | 44篇 |
1986年 | 48篇 |
1985年 | 43篇 |
1984年 | 36篇 |
1983年 | 36篇 |
1982年 | 47篇 |
1981年 | 28篇 |
1980年 | 28篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1976年 | 12篇 |
1975年 | 8篇 |
1974年 | 11篇 |
1933年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Maggio Emilia Mete Maurizio Sartore Mauro Bauci Francesco Guerriero Massimo Polito Antonio Pertile Grazia 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(3):807-815
Graefe's Archive for Clinical and Experimental Ophthalmology - To report a longitudinal analysis of specific optical coherence tomography (OCT) features in eyes with diabetic macular edema... 相似文献
2.
Andrea Ronchi MD Marco Montella MD Federica Zito Marino BD PhD Giuseppe Argenziano MD PhD Elvira Moscarella MD Gabriella Brancaccio MD Giuseppe Ferraro MD Giovanni Francesco Nicoletti MD Teresa Troiani MD Renato Franco MD PhD Immacolata Cozzolino MD PhD 《Cancer cytopathology》2022,130(1):18-29
Malignant melanoma (MM) is a highly aggressive neoplasm with a growing worldwide incidence. It is not uncommon that the disease is already metastatic at the time of the first diagnosis. Regional lymph nodes and skin are the first and most common metastatic sites, followed by distant visceral sites (lungs, liver, and central nervous system) and bone. In this clinical setting, fine-needle aspiration (FNA) often represents the first diagnostic approach. FNA is a useful tool to obtain a rapid and accurate diagnosis, in conjunction with ancillary techniques and molecular analysis, as recommended by recent guidelines. The aim of this review was to describe the cytomorphology, immunocytochemical tools, and molecular tools used for the diagnosis of MM metastases on FNA. 相似文献
3.
4.
5.
Ruscitti Piero Di Cola Ilenia Berardicurti Onorina Conforti Alessandro Iacono Daniela Pantano Ilenia Rozza Gelsomina Rossi Silvia De Stefano Ludovico Balduzzi Silvia Vitale Antonio Caso Francesco Costa Luisa Prete Marcella Navarini Luca Atzeni Fabiola Guggino Giuliana Perosa Federico Cantarini Luca Frediani Bruno Montecucco Carlomaurizio Ciccia Francesco Giacomelli Roberto Cipriani Paola 《Clinical rheumatology》2022,41(11):3597-3597
Clinical Rheumatology - 相似文献
6.
Cifuentes-Faura Javier Di Francesco Renaud 《The European journal of health economics》2022,23(4):559-563
The European Journal of Health Economics - 相似文献
7.
Francesca Bodega Anita Russi Francesco Melillo Fabiana Blunda Claudia Rubino Giulio Leo Alberto Cappelletti Patrizio Mazzone Paolo Mattiello Paolo Della Bella Alessandro Castiglioni Ottavio Alfieri Michele De Bonis Matteo Montorfano Moreno Tresoldi Massimo Filippi Anna Salerno Michela Cera Alberto Zangrillo Margonato Alberto Cosmo Godino 《European journal of clinical investigation》2022,52(1):e13658
8.
Alessia Cimadamore Liang Cheng Marina Scarpelli Francesco Massari Veronica Mollica Matteo Santoni Antonio Lopez-Beltran Rodolfo Montironi Holger Moch 《Translational andrology and urology》2021,10(3):1506
In 1952, renal cell carcinomas had been divided into 2 categories—clear cell or granular cell—depending upon their cytoplasmic staining characteristics. In the following years, the inventory of renal epithelial tumors has expanded by the addition of tumors named by their architectural pattern (i.e., papillary RCC, tubulocystic RCC), anatomic location (i.e., collecting duct carcinoma, renal medullary carcinoma), associated diseases (i.e., acquired cystic disease-associated RCCs). With the extensive application of molecular diagnostic techniques, it becomes possible to detect genetic distinctions between various types of renal neoplasm and discover new entities, otherwise misdiagnosed or diagnosed as unclassified RCC. Some tumors such as ALK rearrangement-associated RCC, MiT family translocation renal carcinomas, SDH-deficient renal cancer or FH-deficient RCC, are defined by their molecular characteristics. The most recent World Health Organization (WHO) classification of renal neoplasms account for more than 50 entities and provisional entities. New entities might be included in the upcoming WHO classification. The aim of this review is to summarise and discuss the newly acquired data and evidence on the clinical, pathological, molecular features and on the prognosis of new RCC entities, which will hopefully increase the awareness and the acceptance of these entities among clinicians and improve prognostication for individual patients. 相似文献
9.
Elisabetta Todisco Federica Gigli Mara Mantiero Simona Sammassimo Rocco Pastano Chiara Ronchini Gabriella Parma Maria Teresa Lapresa Anna Paola Iori Francesco Bertolini Chiara Corsini Giuliana Gregato Claudia Poletti Nicoletta Colombo Corrado Tarella 《International journal of cancer. Journal international du cancer》2021,148(1):170-177
We investigated the occurrence and management of therapy‐related hematological disorders (tr‐HDs) in women with epithelial ovarian cancer (EOC) exposed to poly‐ADP‐ribose polymerase inhibitors (PARPi), after previous chemotherapy. We analyzed 130 consecutive EOC patients treated with PARPi at the European Institute of Oncology, Milan. In line with the literature, overall survival of the entire population was 37% at 5.5 years (89% were advanced stages). Cell blood counts were collected prior to start PARPi, at each new cycle and at monthly intervals. Patients displaying persistent and/or marked hematological abnormalities underwent bone marrow evaluation, with cytogenetic and molecular analysis. Nine patients (6,9%) developed tr‐HDs, after a median 22.8 months of PARPi exposure. Two patients died early and could not be treated. Two patients have no indication for active treatment and are presently under close hematological monitoring. Five patients underwent chemotherapy followed, in three cases, by allogeneic hematopoietic transplantation: three patients are in complete remission of their hematological and gynecological malignancies at 13, 19, and 25 months; the remaining two patients died due to progression of their hematological disease. We show the potential risk of hematological disorders in EOC patients treated with chemotherapy and prolonged PARPi therapy. In our series, tr‐HDs incidence was higher compared to recent reports in large series. Our observations suggest careful monitoring in order to conclusively define, on large series and prolonged follow‐up, the actual risk of tr‐HDs in patients under PARPi. Notably, prompt diagnosis of hematological abnormalities and appropriate management allow achievement of remission from severe hematological complications, at least in most patients. 相似文献
10.
Aldo Cannata Silvia Cantoni Antonio Sciortino Giuseppe Bruschi Claudio Francesco Russo 《Journal of the American College of Cardiology》2021,77(18):2323-2334
Mechanical intravascular hemolysis is frequently observed following procedures on heart valves and uncommonly observed in native valvular disease. In most cases, its severity is mild. Nevertheless, it can be clinically significant and even life threatening, requiring multiple blood transfusions and renal replacement therapy. This paper reviews the current knowledge on mechanical intravascular hemolysis in valvular disease, before and after correction, focusing on pathophysiology, approach to diagnosis, and impact of other hematological conditions on the resultant anemia. The importance of a multidisciplinary management is underscored. Laboratory data are provided about subclinical hemolysis that is commonly observed following the implantation of surgical and transcatheter valve prostheses and devices. Finally, clinical scenarios are reviewed and current medical and surgical treatments are discussed, including alternative options for inoperable patients. 相似文献